Acquisition by Mark Alles of 33809 shares of Celgene subject to Rule 16b-3

Filed transaction by Celgene Corp director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Published over a year ago
View all stories for Celgene | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Transaction by Mark Alles

How important is Celgene's Liquidity

Celgene financial leverage refers to using borrowed capital as a funding source to finance Celgene ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Celgene financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Celgene's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Celgene's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Celgene's total debt and its cash.

An Additional Perspective On Celgene

Celgene Corporation insider trading alert for grant of performance stock unit by Mark Alles, CEO CHAIRMAN OF BOARD, on January 30, 2019. This event was filed by Celgene Corp with SEC on 2019-01-30. Statement of changes in beneficial ownership - SEC Form 4

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect